Targeting the Bone Marrow in Waldenstrom Macroglobulinemia
- 30 June 2011
- journal article
- review article
- Published by Elsevier BV in Clinical Lymphoma Myeloma and Leukemia
- Vol. 11 (Suppl 1), S65-S69
- https://doi.org/10.1016/j.clml.2011.03.022
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Bone progenitor dysfunction induces myelodysplasia and secondary leukaemiaNature, 2010
- Clinical and Translational Studies of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed or Relapsed/Refractory Waldenström's MacroglobulinemiaClinical Cancer Research, 2010
- Pten in stromal fibroblasts suppresses mammary epithelial tumoursNature, 2009
- Src Tyrosine Kinase Regulates Adhesion and Chemotaxis in Waldenstrom MacroglobulinemiaClinical Cancer Research, 2009
- Nf1-Dependent Tumors Require a Microenvironment Containing Nf1+/−- and c-kit-Dependent Bone MarrowCell, 2008
- Location, Location, Location: The Cancer Stem Cell NicheCell Stem Cell, 2007
- Rb Regulates Interactions between Hematopoietic Stem Cells and Their Bone Marrow MicroenvironmentCell, 2007
- The stem cell niches in boneJCI Insight, 2006
- Exploiting the PI3K/AKT Pathway for Cancer Drug DiscoveryNature Reviews Drug Discovery, 2005
- Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar developmentNature, 1998